Published in Women's Health Weekly, February 8th, 1999
A CDC analysis of U.S. HIV/AIDS trends, based on surveillance data collected by June 1998, shows dramatic reductions in perinatal AIDS transmission. According to CDC researcher M.L. Lindegren, these reductions are due principally to increased maternal use of zidovudine (AZT) during pregnancy.
"The elimination of perinatal HIV transmission may be possible," Lindegren suggested in a presentation to the 6th Conference on Retroviruses and Opportunistic Infections, held January 31 - February...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.